CGF treatment of leg ulcers: A randomized controlled trial
- Resource Type
- research-article
- Authors
- Amato, Bruno; Farina, Michele Angelo; Campisi, Silvana; Ciliberti, Marino; Donna, Vincenzo Di; Florio, Anna; Grasso, Antonino; Miranda, Rosario; Pompeo, Francesco; Farina, Eleonora; Serra, Raffaele; Cirocchi, Roberto; Calemma, Francesca; Rocca, Aldo; Compagna, Rita
- Source
- Open Medicine. 14(1):959-967
- Subject
- Concentrated Growth Factors
CGF
Platlet Rich Plasma
PRP
Mixed ulcers
Vascular ulcers
Leg ulcers
Research Article
- Language
- English
- ISSN
- 2391-5463
Background Concentrated Growth Factors (CGF) is a concentration of second generation autologous growth factors compared to platelet rich plasma (PRP) and represents a multifactorial stimulation system that can be used for the management and treatment of chronic skin ulcers. Aim The aim of this work is to evaluate the additional benefits of the CGF compared to the standard of dressing and its effects on the dynamics of the healing process. Methods Autologous CGFs were obtained from 100 patients with chronic mixed ulcers (venous ulcers in patients with II stage claudication) of the lower limbs in a multicentric controlled randomized study. Results The results showed a significant advantage in the use of CGF in association with cleansing and selective compression in the healing time and stabilization of mixed ulcers of the lower extremities. Conclusions These results support the CGF’s clinical use for improving clinical outcomes in mixed ulcers of the legs.